Microrna-15A-5P Down-Regulation Inhibits Cervical Cancer by Targeting TP53INP1 in Vitro
Total Page:16
File Type:pdf, Size:1020Kb
European Review for Medical and Pharmacological Sciences 2019; 23: 8219-8229 MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro X.-Q. ZHAO1, H. TANG2, J. YANG2, X.-Y. GU2, S.-M. WANG2, Y. DING2 1Medical School of Nantong University, Nantong, China 2Department of Endoscopic Diagnostic and Treatment Center, Women’s Hospital of Nanjing Medical University, Nanjing, China Abstract. – OBJECTIVE: An increasing num- Key Words: ber of reports have shown that microRNAs (miR- Cervical cancer, Apoptosis, MicroRNA-15a-5p, NAs) play a vital role in the occurrence and de- TP53INP1. velopment of cancer by acting as tumor inhib- itors or oncogenes. The purpose of this re- search was to explore whether the expression level of microRNA-15a-5p (miR-15a-5p) was re- Introduction lated to TP53 regulated inhibitor of apoptosis 1 (TP53INP1) in cervical cancer, and to explore the role of miR-15a-5p in cervical cancer in vitro. Cervical cancer, one of the most common PATIENTS AND METHODS: Human cervi- malignancies in females1,2, has become the main cal cancer tissues and adjacent normal tis- health issue of women for high morbidity and sues were obtained from 30 cervical cancer mortality3, especially in young women4,5. Com- patients. Firstly, we carried out the quantita- bined treatments have been a standard therapeu- tive Real Time-PCR (qRT-PCR) assay to eval- tic method for cervical cancer patients, including uate the level of miR-15a-5p in cervical can- 6 cer tissues and cell lines. The TargetScan and chemotherapy and radiotherapy . Also, radio- the Dual-Luciferase Reporter Assay were used therapy alone has been used for cervical cancer 7 to confirm the relationship between TP53INP1 at the early stage of cervical cancer . However, and miR-15a-5p. Besides, the Cell Counting Kit- low radiosensitivity, hypoxia, cellular glutathi- 8 (CCK-8) and the flow cytometry analysis were one, or other elements may result in the re-oc- performed to detect the effect of miR-15a-5p on currence of cervical cancer8,9. Thus, the basic cell proliferation and apoptosis in cervical can- research on the pathogenesis of cervical cancer is cer cells. very necessary to lessen the recurrence rate and RESULTS: Our results showed that the expres- sion of miR-15a-5p was enhanced in cervical advance the clinical treatment of cervical cancer. cancer tissues and cells lines. The data from the Particularly, the biological functions and the reg- Dual-Luciferase Reporter Assay demonstrated ulatory effects of the relative genes in cervical that TP53INP1 was a direct target of miR-15a-5p. cancer need to be explored. Besides, the specif- We also found that TP53INP1 was down-regulat- ic targets or genes for cervical cancer remain ed in the cervical cancer tissues and cell lines largely unknown. In this research, we investi- compared with the adjacent normal tissues and gated the molecular mechanism correlated with normal cervical cells. Besides, the down-reg- the tumorigenesis and development of cervical ulation of miR-15a-5p depressed cervical can- cer cell proliferation and enhanced cell apop- cancer and seek novel cure targets for cervical tosis. Our results clearly suggested that the cancer. MicroRNAs (miRNAs), a group of small down-regulation of TP53INP1 successfully im- non-coding RNAs with 20-22 nucleotides, can paired the tumor-inhibition effects of miR-15a- be directly combined with the 3′-untranslated re- 5p inhibitor in cervical cancer cells. gion (3′-UTR) of target genes to regulate the ex- CONCLUSIONS: Our findings indicated that pression of the target genes10. In various cancers, miR-15a-5p functioned as a tumor-promoting miRNAs can act as a part of oncogenic or tumor gene in cervical cancer by directly targeting inhibitors to regulate the tumor formation and TP53INP1, indicating that miR-15a-5p might be 11 a potential treatment target for cervical cancer the expression of their target genes . As we all patients. know, many studies have revealed that miRNAs Corresponding Author: Ye Ding, MD; e-mail: [email protected] 8219 X.-Q. Zhao, H. Tang, J. Yang, X.-Y. Gu, S.-M. Wang, Y. Ding play important roles in various cancer types, Cell Culture including colorectal cancer12, breast cancer13,14, The human cervical cancer cell lines HeLa, cervical cancer15-18, hepatic carcinoma19, and so SiHa, and the human normal cervical cell line on. Moreover, miRNAs are involved in cellular H8 were provided by the American Type Culture proliferation, differentiation, apoptosis, and pro- Collection (ATCC, Manassas, VA, USA). The cell gression. Thus, focusing on the unknown miR- lines were cultivated in the Roswell Park Memo- NAs could be a new insight into the treatment rial Institute-1640 (RPMI-1640; Gibco, Carlsbad, of cancer. Among plentiful tumors inhibiting CA, USA), supplemented with 10% fetal bovine miRNAs, miR-15a-5p belongs to miR-15a fam- serum (FBS; Gibco, Carlsbad, CA, USA), 1% ily and was found to regulate many biological penicillin/ streptomycin, and were incubated at behaviors, for example, cell proliferation, apop- 37°C in a humidified chamber supplemented with tosis, migration, and invasion in various human 5% CO2. cancer cell lines20-23. TP53INP1, TP53 regulated inhibitor of apoptosis 1, was down-regulated in Cell Transfection various cancers, correlates with poor prognosis HeLa and SiHa cells were seeded in the 6-well and cancer relapse24,25. However, the functional plates at a density of 2.0×106 per well and trans- roles of miR-15a-5p and TP53INP1 in human fected with the TP53INP1-siRNA, control-siR- cervical cancer are still unknown. Therefore, the NA, inhibitor control, miR-15a-5p inhibitor, or aim of this study was to investigate the effect of miR-15a-5p inhibitor+TP53INP1-siRNA for 48 miR-15a-5p and TP53INP1 on the progression h by Lipofectamine 2000 (Invitrogen, Carlsbad, of cervical cancer and to explore the poten- CA, USA) according to the manufacturer’s man- tial mechanism. In this paper, we found that ual. After transfection, the cells were collected miR-15a-5p was aberrantly up-regulated both in for further experiments. The efficiency of cell cervical cancer cell lines and clinical cervical transfection was detected by the qRT-PCR and cancer tissues. Then, we conducted molecular Western blot assay. biology and bioinformatics methods to suggest that TP53INP1 was the direct target of miR-15a- CCK-8 Assay 5p in cervical cancer. Besides, we observed that The Cell Counting Kit-8 (Sigma-Aldrich, St. the down-regulation of miR-15a-5p suppressed Louis, MO, USA) was carried out to measure cell cell proliferation and induced cell apoptosis in proliferation following the manufacturer’s proto- cervical cancer cells by targeting TP53INP1. cols. In brief, the cells were seeded in 96-well In addition, miR-15a-5p down-regulation could plates and cultured for 24 h. Then, the cells were also affect the relative gene expression, such transfected with the inhibitor control, miR-15a-3p as TP53INP1, Bcl-2, Bax, and Bcl-2, while its inhibitor, or miR-15a-3p inhibitor+TP53INP1-siR- effects could be reversed by TP53INP1-siRNA. NA for 48 h and then, we added 10 µl CCK-8 solu- Therefore, our results demonstrated important tion to each well and incubated them for another roles of miR-15a-5p in the pathogenesis of cervi- hour at 37°C. The microplate reader (Eon, Bio- cal cancer and indicated its potential functions in Teck, Winooski, VT, USA) was used to measure cervical cancer therapy. the optical density (OD) at 450 nm. Dual-Luciferase Reporter Assay Patients and Methods The TargetScan Release 7.1 (www.targetscan. org/vert_71) was used to predict the relationship Clinical Specimens Collection between miR-15a-5p and TP53INP1. The results The human cervical cancer tissues and the suggested that TP53INP1 was the potential target adjacent normal tissues were obtained from 30 of miR-15a-5p. Then, TP53INP1 3’-UTR DNA cervical cancer patients from the Women’s Hos- segments containing the target sequence of miR- pital of Nanjing Medical University. These spec- 15a-5p were inserted into a pmirGLO vector imens were stored in liquid nitrogen or at -80°C (Promega, Madison, WI, USA) to form the re- for future use. The experiment was approved by porter vector TP53INP1-wild-type (TP53INP1- the Ethics Committee of Women’s Hospital of WT). Also, the mutant 3’-UTRs of TP53INP1 Nanjing Medical University. All patients were was inserted into a Luciferase reporter vector notified that their specimens would be used in (pmiR-REPORT, Ambion, Austin, TX, USA) to this research. form TP53INP1-mutated-type (TP53INP1-MUT) 8220 MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro constructs. Then, the mimic control or miR-15a- Western Blot Assay 5p mimic and TP53INP1-WT or TP53INP1-MUT The cervical cancer cells were washed with were co-transfected into 293 T cells with Lipo- ice-cold PBS and then lysed with RIPA buffer fectamine-2000 (Invitrogen, CA, USA) for 48 (Beyotime Biotechnology, Shanghai, China), h. The Dual-Luciferase Reporter Assay System centrifuged at 12.000 rpm for 30 min at 4°C. (Promega, Madison, WI, USA) was performed The Total Protein Extraction Kit (Phygene Life to detect the Luciferase activity according to Sciences, Shanghai, China) was employed to the manufacturer’s instructions. The experiments extract the total protein. The protein concentra- were carried out at least in triplicate. tion was evaluated by a BCA protein kit (Beyo- time Biotechnology, Haimen, China). Then, 40 Quantitative Real Time-PCR μg of protein were loaded onto 10% SDS-PAGE (qRT-PCR) Assay and then transferred into polyvinylidene diflu- The total RNA was extracted from cervi- oride (PVDF) membrane. Then, the membrane cal cancer cell lines or tissues using TRIzol was blocked with 5% non-fat milk in PBST (Invitrogen, Carlsbad, CA, USA) following the at room temperature for 1 h and incubated manufacturer’s instruction.